Advertisement
Advertisement

Swiss drugmaker Novartis resumes Ukraine business

By:
Reuters
Updated: Jun 2, 2022, 06:09 UTC

ZURICH (Reuters) - Novartis is resuming business in Ukraine after reviewing how safe it was to operate in the country that Russia invaded in February, the Swiss drugmaker said.

Logo is seen at new factory of Novartis in Stein

ZURICH (Reuters) – Novartis is resuming business in Ukraine after reviewing how safe it was to operate in the country that Russia invaded in February, the Swiss drugmaker said.

“After studying current safety protocols in the country, and on advice which we will regularly review, we have begun to resume business operations remotely to help the war-torn country restore some basic critical business processes,” Novartis said on its website in a post dated June 1.

“The safety and security of our people remains our number one objective, and we will constantly review the situation and our business operations in Ukraine.”

Novartis said it condemned the war in Ukraine and has been providing humanitarian support, financial donations and medicine to people there. Russia describes its invasion as a “special military operation” to disarm and “de-Nazify” its neighbour.

(Reporting by Paul Arnold and Michael Shields; Editing by Muralikumar Anantharaman)

About the Author

Reuterscontributor

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products:

Did you find this article useful?

Advertisement